Kazia Therapeutics Ltd - Company Profile

All the data and insights you need on Kazia Therapeutics Ltd in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Kazia Therapeutics Ltd Strategy Report
Understand Kazia Therapeutics Ltd position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Kazia Therapeutics Ltd: Premium Databases

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 3 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	17 Apr 2018	Lorem
Kazia seeks preclinical CRO for toxicology study of lead drug candidate to start in 2H18, CEO says	17 Apr 2018	Alaric DeArment
Novogen in advanced talks with CRO partner for ovarian cancer drug	29 Apr 2015	Manasi Vaidya
Novogen needs smaller CROs for Australian cancer trials, larger CRO for multinational neuroblastoma study - CEO	10 Feb 2015	Alaric DeArment

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Kazia Therapeutics Ltd and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer